A Mortal Complication in a Case with Mucopolysaccharidosis type I Following Hematopoietic Stem Cell Transplantation: Pulmonary Haemorrhage
PDF
Cite
Share
Request
Case report
VOLUME: 11 ISSUE: 2
P: 198 - 201
2021

A Mortal Complication in a Case with Mucopolysaccharidosis type I Following Hematopoietic Stem Cell Transplantation: Pulmonary Haemorrhage

J Dr Behcet Uz Child Hosp 2021;11(2):198-201
1. Ege University Department of Pediatrics, Division of Metabolism and Nutrition, Izmir, Turkey
2. Tepecik Train and Research Hospital, Division of Hematology, Izmir, Turkey
3. Tepecik Train and Research Hospital, Division of Metabolism and Nutrition, Izmir, Turkey
4. Ege University Department of Genetics, Izmir Turkey
5. Ege University Department of Pediatrics, Division of Oncology Izmir, Turkey
No information available.
No information available
Received Date: 2020-09-16T11:50:22
Accepted Date: 2021-08-03T17:20:01
PDF
Cite
Share
Request

Abstract

Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease due to mutations within the gene IDUA encoding the “α-L-iduronidase”. The clinical manifestations concern multisystemic involvement. There are two disease modifying therapies, enzyme replacement therapy and haematopoietic stem cell transplantation (HSCT). Pulmonary haemorrhage (PH) is a rare complication of HSCT and the case was presented with the reason that the related reports were few in MPS I.

Keywords:
MPS I, HSCT, pulmonary haemorrhage